Pembrolizumab for previously treated advanced hepatocellular carcinoma [ID1458]
Discontinued
Reference number: GID-TA10380
As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of pembrolizumab for previously treated advanced hepatocellular carcinoma.
Please note that the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late April 2019.